Neuland Laboratories shares surge over 12% on heavy volumes

Shares of Neuland Laboratories, the Hyderabad-based Active Pharmaceutical Ingredient (API) and Contract Development and Manufacturing Organisation (CDMO), rose as much as 12.55% to hit an intraday high of ₹13,849.95 on the BSE on the back of heavier than usual trading volumes. On the National Stock Exchange, Neuland Laboratories shares rose as much as 12.59% to hit an intraday high of ₹13,850.

Trading volumes in Neuland Laboratories shares surged by over 9 times to 6.32 lakh shares against average trading volume of 67,077 shares. As many as 71,000 shares changed hands on the BSE as against an average of 2,419 shares traded daily in the past two weeks.

Neuland Laboratories came on investors radar ahead of record date for dividend (July 18). The company had declared a dividend of ₹12 per share on May 15 when it decaled fourth quarter financial result.

Neuland Laboratories in fourth quarter of financial year 2024-25 reported net profit of ₹28 crore as against ₹68 crore in the same period last year.

Its revenue from operations fell 15% to ₹328 crore from ₹385 crore.

“Neuland Laboratories had approved re-appointment of Davuluri Saharsh Rao as Whole Time Director, designated as Vice Chairman & Managing Director, for a further period of 5 (five) years, w.e.f. June 1, 2025, basis the recommendation of the Nomination and Remuneration Committee, subject to the approval of the shareholders of the Company in the ensuing AGM,” Neuland Laboratories said.

The stock is trading at price-to-earnings (PE) ratio of over 50 times from past four trading sessions, data from BSE showed. The company will hold its 41st annual general meeting on July 30.

As of 12:18 pm, Neuland Laboratories shares traded 11.98% higher at ₹13,780, outperforming the BSE500 index which was trading on a flat note.